Nature Reviews Clinical Oncology
Vol. 22, Issue 2
Issue 2
2025
8
Articles
Articles in this Issue
cfDNA screening for fetal aneuploidy facilitates maternal cancer detection
David Killock
Feb 01, 2025
pp. 79-79
10.1038/s41571-024-00981-0
Adding blinatumomab to chemotherapy reduces recurrence risk in standard-risk paediatric B-ALL
Peter Sidaway
Feb 01, 2025
pp. 79-79
10.1038/s41571-024-00980-1
Ipilimumab plus nivolumab efficacious in patients with dMMR/MSI-H disease
Peter Sidaway
Feb 01, 2025
pp. 79-79
10.1038/s41571-024-00978-9
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
Maryann Zhao, Jonathan D. Schoenfeld, Ann Marie Egloff et al.
Feb 01, 2025
pp. 83-94
10.1038/s41571-024-00969-w
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja et al.
Feb 01, 2025
pp. 134-154
10.1038/s41571-024-00970-3
Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer
Tina Cascone, William N. William
Feb 01, 2025
pp. 81-82
10.1038/s41571-024-00976-x
Getting the right combination to break the epigenetic code
Seda S. Tolu, Aaron D. Viny, Jennifer E. Amengual et al.
Feb 01, 2025
pp. 117-133
10.1038/s41571-024-00972-1
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Fei Zhou, Haoyue Guo, Yang Xia et al.
Feb 01, 2025
pp. 95-116
10.1038/s41571-024-00971-2
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English